Watchdog Dodges Legal Bills In £89M Drug Cos. Case
An appellate court ruled on Tuesday that the antitrust watchdog does not have to pay Pfizer and another drug company legal fees it spent defending an £89.4 million ($110 million) case...To view the full article, register now.
Already a subscriber? Click here to view full article